Med Chem Test #1 - intro and drug discovery

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/37

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 5:47 PM on 9/11/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

38 Terms

1
New cards

what are drugs?

chemical that can react with biological system and produce biological response

2
New cards

drug classification in order

  1. pharmacological effect

  2. chemical structure

  3. target system

  4. site of action


3
New cards

definition: pharmacological effect

biological responses.

4
New cards

definition: chemical structure

shared core skeleton.

5
New cards

definition: target system

chemical messenger targeted.

6
New cards

definition: site of action

exact enzyme or receptor target

7
New cards

example: pharmacological effect

analgesics, antibacterials

8
New cards

example: chemical structure

steroids, penicillins, barbiturates

9
New cards

example: target system

antihistamines, cholinergics

10
New cards

example: site of action

anticholinesterases

11
New cards

feature: pharmacological effects

yields wide variety of chemical structures

12
New cards

feature: chemical structure

similar structure often share similar activity

13
New cards

feature: target system

more specific than pharmacological effect

14
New cards

feature: site of action

highly specific

15
New cards

what is medicinal chemistry?

science which deals with discovery or design of new chemicals and their development into useful medicines

16
New cards

medicinal chemistry fields

computational chem, synthesis, itoxicology, metabolism

17
New cards

modern drug development type of benefits + example

societal (eradication TB, increasing HIV patient life expectancy)

18
New cards

modern drug development type of consequences + example

biological (antibiotic resistance) and economic (increased healthcare costs)

19
New cards

Stages of drug discovery and development (DDD) in order:

  1. choose a disease

  2. choose a drug target

  3. identify a bioassay

  4. find a lead compound

  5. isolation, purification and structure determination of lead compound

  6. SARs

  7. pharmacokinetics and metabolism

  8. synthesis issues

  9. toxicological safety evaluation

  10. clinical trials


20
New cards

1) choose a disease

MARKETING DECISION! common, chronic, 1st world diseases. no good competitor

21
New cards

2) choose drug target

understand everything about the disease

22
New cards

3) identify a bioassay

high throuput screening. in-vivo preferred with transgenic animals. in-vitro for quantitated results

23
New cards

4) finding lead compound

test multiple compounds

24
New cards

5) isolation, purification, structure determination of lead compound

only if active compound not known

25
New cards

6) SAR

identifying the pharmacophore

26
New cards

SAR also known as

structure activity relationships

27
New cards

define pharmacophore + person credited for definition.

the bare minimum structure needed to for the drug to work. Paul Ehrlich (1909)

28
New cards

7) pharmacokinetics and metabolism

ADME determined.

29
New cards

define ADME

absorption, distribution, metabolism, and excretion

30
New cards

8) synthesis issues

synthesis of drug while keeping low cost

31
New cards

9) toxicological safety evaluation

Ames test, mammalian studies, NOEAL

32
New cards

define NOEAL

No Adverse Event Level

33
New cards

10) clinical trials

4 phases. IND filed with FDA

34
New cards

clinical trial phase I

first exposure to humans. healthy volunteers

35
New cards

clinical trial phase IIa

first exposure to patients. less than 100 patients

36
New cards

clinical trial phase IIb

100-300 patients. double blind. ONE center

37
New cards

clinical trial phase III

100-3000 patients. multiple centers. 2-10 years

38
New cards

clinical trial phase IV

after market